Allarity rebalances board classes, sets June 13 annual meeting

Allarity Therapeutics, Inc.

Thomas H. Jensen resigned from Class I and immediately re-elected as Class III director, term expires 2028.
Board now consists of one Class I, two Class II, and one Class III director.
Annual meeting set for June 13, 2025; record date April 16, 2025.
Deadline for stockholder proposals and director nominations is April 28, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.